Bayshore Pharmaceuticals recalls
Bayshore Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 2 Sep 2020. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Sep 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why bayshore pharmaceuticals is recalled
Product types
By year
All bayshore pharmaceuticals recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets USP, 500 mg recalledMetformin Hydrochloride | Bayshore Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets USP, 750 mg recalledMetformin Hydrochloride | Bayshore Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.